Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

NIHR Impact Advisory Board


Published: 29 September 2023

Version: 2.0 April 2024

Print this document

The NIHR Impact Advisory Board was established in collaboration with the NIHR Impact Programme, to provide guidance and assess relevance of work from a patients and public, industry, NHS, funder, research, clinical and health and social care perspective.

The board meets 2-3 times annually, via a virtual platform, to discuss the work of the impact programme and share relevant expertise.

Co-chairs of the board

  • Dawn Lawson, Executive Director of Strategy & Change, South West Yorkshire Partnership NHS Foundation Trust, Co-Chair

About Dawn:

Since beginning her career working with people with learning disabilities in the NHS and 3rd sector, Dawn was an early career researcher with a focus on people with learning disabilities and health inequities. Since then, Dawn has had a varied career, holding senior and executive level positions across the NHS, achieving impact in complex and uncertain settings. Dawn is a collaborative leader who has experience of leading in complex systems, working across the health and academic sectors and the life sciences industry. A strategic leader who has worked across the knowledge, research and innovation pipeline, from experimental medicine to adoption and spread.

An experienced leader with a strong and varied portfolio of working across complex, fragmented systems and sectors. Dawn has a strong commitment to, and personal belief in, the importance of research and innovation to healthcare services and has a track record of implementing improvement and innovation that leads to tangible change for patients.

  • Catherine White, Public Contributor, Co-Chair

About Catherine:

Catherine has been involved with healthcare and clinical research since 2007. She is currently the blog editor for the European Association for Palliative Care, and she is appointed by the Secretary of State to be an appeal panel member for NICE’s Technology appraisal and highly specialised technologies appeals.

She was a volunteer with the charity ICUsteps from 2007-2023. Previous roles also include a lay member for South Warks Clinical Commissioning Group, Chief Executive for ICUsteps for one year and a chair for NICE Guideline 204 Babies, Children and Young People’s Experience of Healthcare (published in August 2021).

Board members

  • Alison Austin, Deputy Director for Research, NHS England
  • Neville Young, Director of Innovation and Enterprise at YHAHSN
  • Catriona Manville, Director of Policy and Public Affairs at the Association of Medical Research Charities
  • Alexander Politt, Director of Research at the Policy Institute at KCL
  • Ian Viney, Director of Strategic Evaluation and Impact at the Medical Research Council
  • Jo Rycroft, Malone Programme Director and Chair of the Health and Social Care Delivery Research (HSDR) Programme
  • Linda Parton, Public Contributor
  • Emily Wheeler,  Director of Research Partnerships & Development at MQ Mental Health Research
  • Andrew Payne, Group Operations Director and Sales, Management Consultancy at The SA Group (retired)
  • Marios Adamou, Consultant Psychiatrist/ Clinical Lead, South West Yorkshire Partnership NHS FT/ University of Huddersfield